Chronic obstructive pulmonary disease ( COPD) is a chronic inflammatory multisystem disease caused primarily by inhaled noxious substances in combination with environmental factors and genetic predispositions. The presence of such a disease means that the comorbidities associated with COPD should be taken into account in both diagnosis and treatment. First and foremost, cardiovascular comorbidities should be mentioned. In the advanced stage, osteoporosis and muscle hypotrophy are important comorbidities that should be addressed.
Autoren
- PD Dr. med. Sebastian Fähndrich
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Cutaneous Crohn's disease
Effective alternative to TNF inhibitors
- Palliative care symptom and needs assessment.
What screening tools are helpful?
- Benralizumab in a patient with asthma and EGPA
When the biologic has a counterproductive effect
- Brain atrophy and MS
Brain atrophy correlates with disability progression in MS
- Alternative to insulin and GLP1
From the β-cell to the center: the versatile role of amylin
- Diabetes mellitus
Treatment of comorbidities in older people
- Pulmonary sarcoidosis
Prednisone vs. MTX: a draw after 24 weeks
- Friedreich's ataxia